The 1991 Budget: More Promises, Less Money

WASHINGTON—Although the 1991 budget that President Bush will present to Congress next month is expected to propose bigger budgets for many science research programs, the sobering truth is that there isn’t going to be enough money available to support the programs. The budget, still in preparation and scheduled to be delivered January 8 to Congress, is expected to contain major increases in a variety of scientific projects already under way. The figures could be as large as $400 m

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

WASHINGTON—Although the 1991 budget that President Bush will present to Congress next month is expected to propose bigger budgets for many science research programs, the sobering truth is that there isn’t going to be enough money available to support the programs.

The budget, still in preparation and scheduled to be delivered January 8 to Congress, is expected to contain major increases in a variety of scientific projects already under way. The figures could be as large as $400 million for the Superconduct ing Supercollider (SSC), up from $225 million this year; $2.7 billion for the space Station, up from $1.85 billion this year; and $200 million for the human genome project, up from $91 million this year. The National Science Foundation is also expected to get another healthy increase, part of the administration’s oft-repeated promise to double its budget within five years.

The president’s budget may also contain addenda that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies